CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: August 29, 2006
Result type: Reports
Project Number: SR0072-000
Product Line: Reimbursement Review

Generic Name: Darunavir

Brand Name: Prezista

Manufacturer: Janssen-Ortho Inc.

Therapeutic Area: HIV infection

Indications: HIV infection

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: February 14, 2007

Recommendation Type: List with clinical criteria and/or conditions